S16L (p.Ser16Leu) variant of IDUA (Alpha-L-iduronidase)

S16L (p.Ser16Leu) in IDUA (Alpha-L-iduronidase) is a missense change. Clinical records from EBI and UniProt describe it as pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data and structural context.

S16L (p.Ser16Leu) variant details